Shopping Cart
- Remove All
![TargetMol](https://newstatic.targetmol.com/error/oops.webp)
Your shopping cart is currently empty
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $97 | In Stock | |
5 mg | $247 | In Stock | |
10 mg | $397 | In Stock | |
25 mg | $663 | In Stock | |
50 mg | $945 | In Stock | |
100 mg | $1,280 | In Stock | |
500 mg | $2,570 | In Stock | |
1 mL x 10 mM (in DMSO) | $272 | In Stock |
Description | AZA1 (Rac1/Cdc42-IN-1) is a potent dual inhibitor of Rac1 and Cdc42. AZA1 induced apoptosis of prostate cancer cells and inhibited cell proliferation, migration and invasion. |
In vitro | AZA1 (Rac1/Cdc42-IN-1) (2-10 μM; 72 hours) impedes the proliferation of human 22Rv1 prostate cancer cells.[1] AZA1 (2-10 μM; 24 hours) diminishes phosphorylation of PAK1, AKT, and BAD in EGF-stimulated 22Rv1 prostate cancer cells.[1] AZA1 (10 μM; 24 hours) obstructs Rac1 and Cdc42-dependent cell cycle progression in 22Rv1 prostate cancer cells. AZA1 inhibits Rac1 and Cdc42-dependent migration of 22Rv1, DU 145, and PC-3 prostate cancer cells.[1] AZA1 influences cell motility and actin reorganization in prostate cancer cells by suppressing Rac1 and Cdc42 function through PAK1/2 phosphorylation.[1] |
In vivo | AZA1 (Rac1/Cdc42-IN-1) (100 μg; i.p.; daily for 2 weeks) is potent in suppressing human 22Rv1 xenograft growth in mice (5 week-old athymic nu/nu (nude)) and improving survival. The suppressive effect of AZA1 on tumor growth was significant.[1] |
Alias | Rac1/Cdc42-IN-1 |
Molecular Weight | 368.43 |
Formula | C22H20N6 |
Cas No. | 1071098-42-4 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 60 mg/mL (162.85 mM) ![]() | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.